Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

DNAH8 Inhibitors

DNAH8 inhibitors are a class of chemical compounds that exert their effects by specifically targeting and modulating the activity of the DNAH8 enzyme. DNAH8, a member of the dynein family of molecular motors, is known to play a pivotal role within cells, particularly in processes involving intracellular transport and motility. These inhibitors are designed to interact with the catalytic site of the DNAH8 enzyme, where its enzymatic activity is orchestrated. By binding to this active site, the inhibitors disrupt the enzyme's ability to carry out its natural biochemical reactions. The three-dimensional structure of DNAH8, along with the details of its catalytic pocket, serves as a blueprint for the design and optimization of these inhibitors. Computational techniques, such as molecular docking and virtual screening, are often employed to predict and select potential inhibitor molecules that can effectively bind to the DNAH8 active site. Once identified, these potential inhibitors undergo further scrutiny through in vitro and in silico experiments to validate their binding affinity and specificity.

The interaction between DNAH8 and its inhibitors can have far-reaching consequences for cellular function. DNAH8 is known to be involved in the movement of cellular structures, such as cilia and flagella, which are essential for processes like cellular locomotion and the clearance of mucus from the respiratory tract. Additionally, DNAH8 has been implicated in intracellular transport processes that facilitate the movement of organelles and vesicles within cells. Inhibiting DNAH8's enzymatic activity can potentially disrupt these intricate cellular processes, leading to downstream effects on various physiological functions. The development of DNAH8 inhibitors requires a multi-disciplinary approach, combining expertise in molecular biology, structural biology, computational chemistry, and organic synthesis. Researchers often utilize X-ray crystallography and cryo-electron microscopy to determine the detailed structure of DNAH8 and its active site. This structural information is invaluable for the rational design of inhibitors that can fit snugly into the enzyme's catalytic pocket, effectively blocking its activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This is a nucleoside analog that is incorporated into DNA during replication, leading to DNA methylation inhibition and subsequent gene expression changes.

SGI-1027

1020149-73-8sc-473875
10 mg
$213.00
(0)

A compound that inhibits both DNMT1 and DNMT3B, potentially impacting both maintenance and de novo DNA methylation processes.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

Another nucleoside analog that can be incorporated into DNA and lead to DNA hypomethylation, affecting gene expression.